MethylGene is a biopharmaceutical company focused on the discovery, development and commercialization of novel and proprietary enzyme inhibitors for the treatment of cancer and infectious diseases.
Your privacy
BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.
